Medical and Pharmaceutical Industry - Market Research Report

 The global heart attack diagnostics market size is expected to reach USD 18.52 billion by 2030, according to a new report by Grand View Research, Inc. The heart attack diagnostics market is anticipated to grow at a CAGR of 8.2% during the forecast year from 2024 to 2030. The overall risk factors and the disease burden remains large, thereby rendering the heart attack diagnostic sectors a profitable growth prospect. This growth is attributed to a majority of factors, such as high prevalence of coronary heart diseases, increased tobacco smoking, and obesity, enhanced adoption of unhealthy diet is resulting in a high cholesterol incidence in individuals, particularly in the rising geriatric population. However, the low Medicare reimbursement provided for the mobile cardiac outpatient telemetry electrocardiogram (ECG) and the progressively declining heart attack incidence rates are expected to hamper the market growth.   Access the Heart Attack Diagnostics Market Size, Share & Tren

 The global fabry disease treatment market size is estimated to reach a value of USD 4.93 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.9% from 2024 to 2030. Rising cohort of Fabry disease, increasing adoption of novel therapies such as chaperone treatment, and potential approval of pipeline drugs including substrate reduction therapies and enzyme replacement therapies are providing a fillip to the market. Fabry disease is a rare inherited lysosomal storage disorder caused by genetic mutation that interferes with function of alpha galactosidase enzyme. Fabry disease generally has a late onset with mild symptoms, due to which several patients are often undiagnosed. Standard of care for management of the disease is enzyme replacement therapy (ERT). Sanofi’s Fabrazyme and Shire’s Replagal are the only approved ERTs in the EU; however in the U.S., only Fabrazyme has been approved.   Access the Fabry Disease Treatment Market Size, Share

 The global functional protein market size is estimated to reach USD 9.48 billion 2030 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. Rising importance of protein-fortified convenience foods as a result of extensive advertising campaigns by nutraceutical suppliers in e-commerce portals and electronics media is expected to have a substantial impact. Furthermore, the increasing market penetration of powdered drink mixes as a result of product innovation by companies including General Foods Corporation is expected to play a crucial role in promoting the functional proteins consumption in the near future.   Whey protein isolates (WPI) accounted for 26.1% of global industry share in 2016. The segment is expected to witness significant gains owing to the introduction of the product forms in vanilla and chocolate flavors on a global level. Furthermore, increasing awareness towards enhancing muscular strength among athletes as well as gym professionals in emerging markets incl

 The global osteoporosis drugs market size is expected to reach USD 18.80 billion by 2030 and is projected to grow at a CAGR of 3.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. An upsurge rise in the unhealthy lifestyle adoption has resulted in aggravation and increase in the prevalence of osteoporosis which is presumed to propel the osteoporosis drugs market during the forecast period. In addition, growing number of patent expiries is fueling the high clinical urgency to use generic versions of the established drugs, which is presumed to fuel generic osteoporosis drugs market during the forecast period. The aforementioned factors cumulatively are slated to present the with high potential growth opportunities over the coming years. Furthermore, rising number of initiatives to increase the awareness levels pertaining to osteoporosis care amongst the patients as well as the physicians is expected to widen the osteoporosis market growth potential during th

The CIS insulin market size is expected to reach USD 4.67 billion by 2030, registering a CAGR of 5.6% from 2024 to 2030, according to a new report by Grand View Research, Inc.  The presence of an extensive pipeline portfolio of products exhibiting higher efficacies and their subsequent commercialization over the next six years is expected to serve this market as a high impact rendering driver. The introduction of government initiatives aimed at improving the affordability of insulin via price reduction, such as the collaboration between the government of Ukraine and Indar to reduce the price of insulin by 20% in 2013 is expected to have positive influence on demand. Some of the other drivers of this market include increasing attempts made by manufacturers to capitalize on the untapped opportunities by opening new manufacturing units to improve the supply of insulin and growing incidence rates of type II diabetes are some of the factors expected to fuel future market growth.   Acces

 The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period. Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.   Access the Hydrogel-based Drug

 The global military wearable medical devices market size is expected to reach USD 38.77 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 26.3% from 2024 to 2030. The growth of the market is attributed to the improvement in the overall performance of military soldiers with the help of innovative technology and the rising demand for lightweight military devices. The Covid-19 pandemic has transformed the market for military wearable medical devices because wearable technologies could monitor, detect, and prevent the spread of the virus. The Covid-19 virus has indirectly increased the demand for wearable medical devices. According to the WHO guidelines, viral infection mainly spreads through the eyes, nose, and mouth and it is difficult to identify the virus during the initial days of contract. Hence, with the innovative technology, the individual can regularly check and monitor their body temperature, oxygen level, heart rate